Transient forebrain
ischemia induces
calpain-mediated degradation of the neuronal cytoskeleton,
alpha-fodrin, and this results in ischemic neuronal death. In this study, we investigated the spatial distribution and temporal changes of
calpain-catalyzed
alpha-fodrin proteolysis in focal
cerebral ischemia and examined the effects of a
calpain inhibitor.
Ischemia was induced in gerbils by 3-h
middle cerebral artery occlusion followed by reperfusion. Animals were divided into four groups: a
sham-operated group, an ischemic group, a vehicle-treated group, and a
calpain inhibitor-treated group.
Intravenous injections of vehicle or
calpain inhibitor I were administered 30 min before
ischemia.
Infarct volumes were measured 1 day after reperfusion and the spatial distribution of
calpain-catalyzed
alpha-fodrin proteolysis was investigated by immunohistochemistry 15 min, 1 h, 4 h, and 1 day after reperfusion.
Infarct volume (mean +/- SD) in the ischemic group and the vehicle-treated group was 204.6 +/- 19.1 mm3 and 212.4 +/- 16.3 mm3, respectively, and the
calpain inhibitor I reduced the
infarct volume [149.4 +/- 25.2 mm3 (P < 0.05)]. Immunoblot analysis demonstrated that
calpain inhibitor reduced proteolysis.
Ischemia induced
fodrin proteolysis in the ischemic core and the peri-
infarct zone within 15 min after reperfusion, with proteolysis developing quickly in the ischemic core and more slowly in the peri-
infarct zone. Proteolysis preceded neuronal death in the peri-
infarct zone.
Calpain inhibitor I ameliorated neuronal death in the peri-
infarct zone but not in the ischemic core. Thus,
calpain plays a pivotal role on focal
ischemia as well as in global
ischemia.